Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gay M Crooks

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Cell Reports|March 12, 2023
Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cellsSuwen Li, Chloe S Wang, Amélie Montel-Hagen, et al.
Cell Stem Cell|April 8, 2014
Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking studySanggu Kim, Namshin Kim, Angela P Presson, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Molecular Cancer|December 24, 2015
BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemiaNorma I Rodríguez-Malavé, Thilini R Fernando, Parth C Patel, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Plos One|October 12, 2012
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cellsAli Nsair, Katja Schenke-Layland, Ben Van Handel, et al.
Stem Cell Reports|December 28, 2013
Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cellsLing Wu, Carolina Bluguermann, Levon Kyupelyan, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Cell Reports|March 12, 2023
Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cellsSuwen Li, Chloe S Wang, Amélie Montel-Hagen, et al.
Cell Stem Cell|April 8, 2014
Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking studySanggu Kim, Namshin Kim, Angela P Presson, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Molecular Cancer|December 24, 2015
BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemiaNorma I Rodríguez-Malavé, Thilini R Fernando, Parth C Patel, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Plos One|October 12, 2012
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cellsAli Nsair, Katja Schenke-Layland, Ben Van Handel, et al.
Stem Cell Reports|December 28, 2013
Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cellsLing Wu, Carolina Bluguermann, Levon Kyupelyan, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Pageof 10